Codes / ICD10CM / B87.3

B87.3 Nasopharyngeal myiasis

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Nasopharyngeal myiasis

Summary

Nasopharyngeal myiasis is a parasitic infestation of the nasopharynx (the upper part of the throat behind the nose) by fly larvae (maggots). The condition occurs when flies deposit eggs or larvae in the nasopharyngeal region, which then hatch and feed on the host's tissue. It typically presents as a localized infestation, though severity can vary based on the fly species and host factors.

Causes

Nasopharyngeal myiasis is caused by the larvae of certain fly species, such as botflies or blowflies, which deposit eggs or larvae directly in the nasopharynx. The larvae hatch and feed on the host's tissue, leading to infestation. Transmission often occurs through contact with contaminated environments, animals, or flies.

Risk Factors

  • Poor hygiene or inadequate nasal care.
  • Living in or traveling to regions with high fly populations.
  • Nasal or sinus infections, polyps, or structural abnormalities.
  • Prolonged exposure to decaying organic matter.
  • Immunocompromised states or underlying respiratory conditions.

Symptoms

  • Crawling or moving sensations in the nasopharynx.
  • Visible larvae or maggots in the nasal passages or throat.
  • Nasal congestion, discharge, or bleeding.
  • Pain, itching, or irritation in the nasal or throat area.
  • Systemic symptoms (e.g., fever) in severe or invasive cases.

Diagnosis

Diagnosis is primarily clinical, based on the presence of larvae in the nasopharynx. Healthcare providers may examine the nasal passages or throat using direct visualization or endoscopy to confirm the infestation. Laboratory testing is rarely needed unless secondary infections are suspected.

Treatment Options

Treatment typically involves mechanical removal of the larvae, often under local anesthesia or sedation. Topical or systemic antiparasitic medications may be used to eliminate remaining larvae or prevent recurrence. Wound care and management of secondary infections are also important components of treatment.

Prognosis and Follow-Up

With prompt and appropriate treatment, the prognosis for nasopharyngeal myiasis is generally good. Most patients recover fully without long-term complications. Follow-up may be recommended to ensure complete resolution and to monitor for any signs of recurrence or secondary infections.

Complications

  • Secondary bacterial or fungal infections.
  • Tissue damage or scarring in the nasopharynx.
  • Spread of larvae to other areas (rare).
  • Systemic reactions, such as fever or allergic responses.

Lifestyle & Prevention

  • Maintain good nasal hygiene and avoid exposure to flies.
  • Use protective measures (e.g., nets, repellents) in high-risk environments.
  • Seek prompt treatment for nasal or sinus infections to reduce susceptibility.
  • Avoid contact with decaying organic matter or contaminated materials.

When to Seek Professional Help

Seek medical attention if you experience persistent nasal symptoms, visible larvae, or signs of infection (e.g., fever, severe pain). Early intervention can prevent complications and ensure proper management.

Tips for Medical Coders

When coding for nasopharyngeal myiasis (B87.3), ensure documentation clearly specifies the location (nasopharynx) and confirms the presence of larvae. Include details about the clinical presentation, diagnostic methods, and treatment provided to support accurate code assignment. Verify that the code aligns with the specific anatomical site and type of myiasis documented.

Book a walkthrough

B87.3 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.